Lexicon Pharma (LXRX) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.48 +0.03 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.45 | 52 Week High | $19.62 | |||
| Open | $1.47 | 52 Week Low | $7.65 | |||
| Day High | $1.49 | P/E | N/A | |||
| Day Low | $1.44 | EPS | $-0.22 | |||
| Volume | 1,861,652 | |||||
